摘要:
The present invention relates to a method for preparing a target-specific non-antibody protein, and more particularly, to a method for preparing a target-specific non-antibody protein comprising the steps of: selecting non-antibody proteins having a structural complementarity with the target site of a target protein in a non-antibody protein library; calculating a binding energy of the selected non-antibody protein and the target protein; selecting a non-antibody protein having a favorable binding energy among the selected non-antibody proteins; selecting amino acid residues having a high binding energy among the interfacial amino acid residues of the selected non-antibody protein and the target protein; and substituting the selected amino acid residues with the amino acid residues having a low binding energy. In addition, the present invention relates to a target-specific non-antibody specifically binding with EGFR (Epidermal Growth Factor Receptor) domain 2, which is prepared by the method, and a cancer therapeutic composition comprising the same.
摘要:
The present invention relates to a method for preparing a target-specific non-antibody protein, and more particularly, to a method for preparing a target-specific non-antibody protein comprising the steps of: selecting non-antibody proteins having a structural complementarity with the target site of a target protein in a non-antibody protein library; calculating a binding energy of the selected non-antibody protein and the target protein; selecting a non-antibody protein having a favorable binding energy among the selected non-antibody proteins; selecting amino acid residues having a high binding energy among the interfacial amino acid residues of the selected non-antibody protein and the target protein; and substituting the selected amino acid residues with the amino acid residues having a low binding energy. In addition, the present invention relates to a target-specific non-antibody specifically binding with EGFR (Epidermal Growth Factor Receptor) domain 2, which is prepared by the method, and a cancer therapeutic composition comprising the same.
摘要:
A user terminal and a method for managing data related to minimization of drive-tests (MDT) in the user terminal. The method includes entering into an MDT mode, receiving a system parameter from a base station, obtaining MDT-related data DN measured at a current time TN, and updating at least one of an average of the periodically measured MDT-related data ‘DAverage’ and information about distribution of the periodically measured MDT-related data ‘DDistribution’ to reflect DN based on the system parameter. The user terminal includes a measuring unit to measure DN, a memory unit to maintain at least one of ‘DAverage’ and ‘DDistribution’, based on a system parameter received from a base station; and a control unit to update at least one of the ‘DAverage’ and the ‘DDistribution’ based on DN measured at a current time TN.
摘要:
Provided is a method for obtaining and reporting minimization of drive-tests (MDT)-related data and an apparatus for performing the same. The method may include receiving mode signaling message related to performing of an MDT mode, obtaining MDT-related data for measuring a propagation environment around equipment, based on the MDT mode signaling message, maintaining and storing the MDT-related data in a memory, generating an MDT report message including at least one of an average of the MDT-related data DAverage and information about distribution of the MDT-related data DDistribution, and transmitting the MDT report message to a base station.